Drug development in the field of oncology is mired in tradition, resulting in skyrocketing clinical trial costs that translate into increased costs of health care; the status quo is not sustainable.

A clinical trial is a massive investment for the drug manufacturer—an investment of time, effort, and funds that are channeled into preclinical research to identify a target and the right molecule for ...